- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 102.16M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $342.47M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $537.58M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.19B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.29B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.38B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.48B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.97B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.13B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.7B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.85B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 104.4M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $85.89M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $57.5M |
| Capex | Q1 2025 · Mar 31, 2024 | $11.78M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$15.92M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.52B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.59B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.61 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.61 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $521.9M |
| Net Income | Q1 2025 · Mar 31, 2024 | $63.7M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $40.9M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $562.8M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $913.14M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.48B |